Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
- PMID: 36505263
- PMCID: PMC9727393
- DOI: 10.3389/fnut.2022.1019970
Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
Keywords: COVID-19; SARS-CoV-2; dyslipidemia; endocrinology; metabolic disease; nutrition-clinical; obesity.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
References
-
- Akter R, Rahman MH, Bhattacharya T, Kaushik D, Mittal V, Parashar J, et al. . Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments. Environ Sci Pollut Res Int. (2021) 28:68071–89. 10.1007/s11356-021-16809-8 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
